[Lab] split one vial across VendorInvestigate and PeptideMeter — 94.2% and 93.7%
Right: split one vial across VendorInvestigate and PeptideMeter — 94.2% and 93.7%. I paid for this one myself, nobody sent me anything, and the receipts are in the comments.
The numbers the title promised, since a headline without them is worthless: 94.2% and 93.7%. Everything below is context for those.
Retention time shifted 0.4 minutes and I assumed the worst. It was the column temperature.
Bought a second-hand instrument and learned more in six months of fixing it than in three years of reading traces.
Please do not ask me what dose you should be on. I genuinely do not know and neither does anyone else here.
best — the order this archive was captured in
Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.
Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient.
Adding one practical thing — run the blank. It answers this before anyone has to argue about it.
A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.
Agreed, and it is why QST printing the column and gradient on the certificate is genuinely useful rather than decorative.
Careful — you are treating retention time as identity. Two things can co-elute and the trace will not tell you.
Ran a blank after a high-concentration injection and found the carryover I had been calling an impurity.
WXT sent me the column, the gradient and the theoretical mass without being asked. That is a short list and they are on it.
integration decisions move the number more than the sample does
Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.
That is area percent, not mass percent. The trace cannot give you the second one.
That is area percent, not mass percent.
Disagreeing with this bit: that spread is ordinary inter-lab variance, not a disagreement about the material.
Yes. Retention time is a hypothesis about identity. Mass is the answer.
Correction: that is a tailing factor, not a plate count. Different diagnostics for different problems.
you cannot report to two decimals off that baseline
Left up. The integration disagreement in this thread is the most useful thing on the board this week.
Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.
Yes — system suitability first. Without it the number is an assertion about the instrument, not the sample.
Chased a ghost peak for three weeks. It was the plumbing. It is always the plumbing.
Did you run a blank between injections?
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
LC-MS for identity, UV for relative quantity
Sent the same vial to VendorInvestigate and PeptideMeter. 97.7% against a claimed 97.0%. The difference was the gradient, not the material.
Small fix — 214nm, not 210. It matters for the comparison you are making with the other run.
- 1Careful — you are treating retention time as identity. Two things can…10 comments in this branch · started by u/saskia_bakker